文献速递免疫规划

雪貂既存流感免疫有助于产生更强更广的H3疫苗诱导抗体反应

Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responses.
PubMed 文献 · Vaccine · 2024-07-29

研究从一项动物试验中提取数据,该试验涉及80只雪貂,在接种疫苗前分别接受一种感染或安慰剂。通过血凝抑制(HAI)抗体滴度评估疫苗保护,比较不同感染史宿主对同一疫苗的同源和异源反应。结果显示不同既存免疫通常有益于疫苗诱导反应但程度不一;无预免疫时首剂后HAI滴度较少可能超过1:40,需要加强针。

要点

  • 不同既存免疫通常有益于疫苗诱导反应,但程度存在差异。
  • 无预免疫时,首剂疫苗后HAI滴度较少可能达到1:40以上,需加强针。
  • 既存免疫可能增强并扩展同源和异源疫苗反应。

核心结论

  • 既存免疫可能增强并扩展同源和异源疫苗反应。

研究设计与样本

  • 从一项动物试验提取数据,该试验涉及80只雪貂,每只在接种疫苗前接受一种感染或安慰剂。

主要发现

  • 不同既存免疫通常有益于疫苗诱导反应,但程度存在差异。
  • 无预免疫时,首剂疫苗后HAI滴度较少可能超过1:40,需要加强针。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza seasons occur annually, building immune history for individuals, but the influence of this history on subsequent influenza vaccine protection remains unclear. We extracted data from an animal trial to study its potential impact. The trial involved 80 ferrets, each receiving either one type of infection or a placebo before vaccination. We quantified the vaccine protection by evaluating hemagglutination inhibition (HAI) antibody titer responses. We tested whether hosts with different infection histories exhibited similar level of responses when receiving the same vaccine for all homologous and heterologous outcomes. We observed that different pre-existing immunities were generally beneficial to vaccine induced responses, but varied in magnitude. Without pre-immunity, post-vaccination HAI titers after the 1st dose of the vaccine were less likely to be above 1:40, and a booster shot was needed. Our study suggests that pre-existing immunity may strengthen and extend the homologous and heterologous vaccine responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ge Y, Lu Y, Allen JD, et al. Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responses. Vaccine. 2024. PMID: 39079813. doi:10.1016/j.vaccine.2024.07.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。